AI helper
This is a market research notice from the U. S. Food and Drug Administration (FDA) for preventive maintenance and repair services for a Cozzoli vial filling machine used by the Center for Biologics Evaluation and Research (CBER). The FDA is seeking small business sources but also encourages other than small business concerns to submit capability statements. The North American Industry Classification System (NAICS) code is ****, with a small business size standard of $34 million. The scope includes one on-site preventive maintenance visit per year, with consumables, labor, travel, and parts included. The service engineers must be trained and certified, following OEM specifications and using OEM certified parts. Unlimited software and firmware updates, as well as technical support via phone and email, are required. Deliverables include service records and reports. The place of performance is in Silver Spring, MD. The period of performance includes a base period (July 1, 2026 - June 30, 2027) and four option years. The contract type is firm fixed price. Responses should include business name, SAM Unique Entity ID, address, website, size status, point of contact, phone number, email, descriptive literature, three years of past performance information, estimated on-site response time, available service repair agreement plans, and information on GSA schedules or other government-wide contracts. Capability statements are due by email to ***@***. *. * on or before April 28, 2026, by 13:00 hours Central Time. Responses will help determine if the requirement should be set aside for small business, full and open competition, or sole source acquisition. No proprietary, classified, confidential, or sensitive information should be included.
The bid notice does not specify a delivery deadline for the services, but capability statements are due by April 28, 2026.
The bid notice mentions standard commercial warranty and payment terms but does not provide specific details.
The bid notice mentions standard commercial warranty and payment terms but does not provide specific details.
The bid notice is for market research purposes only and is not a request for proposal or solicitation, so an award criterion is not applicable at this stage.
The FDA is seeking small business sources capable of providing the required supplies and services, and other than small business concerns are also encouraged to submit capability statements. Responses must include business name, SAM Unique Entity ID, address, website, size status, point of contact, phone number, email, descriptive literature, three years of past performance information, estimated on-site response time, and available service repair agreement plans.
The bid notice does not mention the submission of samples.
The bid notice does not provide an estimated total value for the services.
